Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.

Journal of the American Heart Association

Volumn 2, Issue 1, 2013, Pages

  Ayaori, Makoto ^a   Iwakami, Naotsugu ^b   Uto Kondo, Harumi ^b   Sato, Hiroki ^b   Sasaki, Makoto ^b   Komatsu, Tomohiro ^b   Iizuka, Maki ^b   Takiguchi, Shunichi ^b   Yakushiji, Emi ^b   Nakaya, Kazuhiro ^b   Yogo, Makiko ^b   Ogura, Masatsune ^b   Takase, Bonpei ^b   Murakami, Takehiko ^b   Ikewaki, Katsunori ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALOGLIPTIN; BIOLOGICAL MARKER; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOSITOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIPERIDINE DERIVATIVE; PYRAZINE DERIVATIVE; SITAGLIPTIN; TRIAZOLE DERIVATIVE; URACIL; VOGLIBOSE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD FLOW; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ENZYMOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INOSITOL; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; PIPERIDINES; PROSPECTIVE STUDIES; PYRAZINES; REGIONAL BLOOD FLOW; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES; URACIL; VASODILATION;

EID: 84884198401     PISSN: None     EISSN: 20479980     Source Type: None    
DOI: 10.1161/JAHA.112.003277     Document Type: Article

References (0)